Healthcare / Medical DistributionBSE
$57.99
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-2.9M · quality 39.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
27/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.8B
P/E
128.9x
↑EV/EBITDA
66.2x
↑ROE
3.9%
↑Gross Margin
21.5%
↓Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-5.1%
FCF CAGR
—
FCF margin
77.4%
FCF / Net income
1.58x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.8M · net income $1.4M · FCF $2.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.8M | $2.8M | $2.8M | $3.0M | $3.3M |
| Net Income | $1.4M | $1.4M | $-1.2M | $-4.4M | $-1.9M |
| EBITDA | $2.2M | $2.2M | $-631455.00 | $-3.8M | $-1.5M |
| EPS | 0.45 | 0.45 | -0.39 | -1.48 | -0.63 |
| Gross Margin | 21.5% | 21.5% | 23.3% | 27.3% | 29.0% |
| Operating Margin | -196.5% | -196.5% | -147.8% | -127.0% | -103.3% |
| Net Margin | 48.8% | 48.8% | -41.9% | -148.2% | -57.7% |
| Balance Sheet | |||||
| Debt/Equity | — | — | 0.02 | 0.02 | — |
| Cash Flow | |||||
| Free Cash Flow | $2.2M | $2.2M | $-2.9M | $-3.8M | $-3.7M |
| Returns | |||||
| ROE | 3.9% | 3.9% | -3.5% | -12.7% | -4.8% |
| Valuation | |||||
| P/E | 128.87 | 128.87 | — | — | — |
| EV/EBITDA | 66.16 | 66.16 | — | — | — |
| P/B | 4.98 | 4.98 | 2.14 | 1.89 | 1.68 |
| Growth & Yield | |||||
| Revenue Growth | -0.3% | -0.3% | -6.6% | -8.3% | — |
| EPS Growth | 215.4% | 215.4% | 73.6% | -134.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
125.3%
EPS terminal req.
$5.15
Spread vs growth
90.1%
5Y implied EPS CAGR
69.1%
EPS terminal req.
$6.23
Spread vs growth
146.3%
10Y implied EPS CAGR
36.4%
EPS terminal req.
$10.03
Spread vs growth
179.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+152.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.39 → 0.45
Residual
+152.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.